ACE-031

ACE-031 is a therapeutic protein peptide that contains a recombinant fusion protein made by joining a human ActRIIB receptor segment to a segment of an antibody from a human.

Muscles become more powerful by reducing the off signal that halts muscle production.

£99,99

Availability: In stock

Description

What Exactly is ACE-031:

ACE-031 peptide was developed to mimic a natural receptor that regulates strength, function and muscle mass. To block the action of myostatin, ACE-031 binds to myostatin and other proteins that regulate myostatin’s function. Myostatin is a crucial protein that prevents muscle cells from growing and developing. Due to an increased number of muscle fibres, animals such as specific cattle breeds can have extremely lean, muscular physiques because they produce less myostatin. ACE-031 prevents myostatin from binding to its own receptors by binding it to the circulation. When myostatin binds to these receptors, they usually shut down muscle growth, but muscle growth is unhindered because ACE-031 prevents myostatin from binding. Researchers found that treating animals and humans with ACE-031 led to gains in lean muscle mass and volume while also improving fat and bone metabolism markers. Some pharmaceutical companies are also investigating ACE-031 as a treatment for various muscle-wasting diseases, including ALS and Duchenne muscular dystrophy (DMD). Myostatin suppression was shown to be a potentially beneficial therapy for ALS treatment, while ACE-031 was found to be a potential therapeutic method for treating DMD.


What is ACE-031 Known For?

Research studies have shown that patients with neuromuscular diseases like muscular dystrophy and amyotrophic lateral sclerosis (ALS) may benefit significantly from ACE-031.

Loss of muscle mass is directly linked to the cause of death in diseases such as amyotrophic lateral sclerosis (ASL) and muscular dystrophy(DMD), where muscle plays an essential role in health. However, to date, researchers know a lot more about the protective effects of ACE-031.

Myostatin-blocking peptides like ACE 031 have been shown in recent studies to reduce muscle and strength loss in animals with renal failure and cancer cachexia. Additionally, they’ve been shown to improve insulin sensitivity, lessen inflammation, reduce body fat, and speed up bone mineralization and healing.


Studies:

https://pubmed.ncbi.nlm.nih.gov/23169607/

https://clinicaltrials.gov/ct2/show/NCT01099761


Effects:

Research has suggested that ACE-031 can have the following benefits:

  • Patients with a neuromuscular disease symptom may benefit, making it a promising treatment for Duchenne muscular dystrophy.
  • Contributes significantly to muscle growth and maintenance.
  • Anti-muscle loss anabolic/anti-catabolic effects are strong.
  • Getting rid of extra pounds of body fat.

Side Effects:

Following a regular ACE 031 cycle, according to research, can enhance the development of skeletal muscle. For example, subjects gained over 1kg of muscle in just two weeks after receiving a single dose of ACE-031. In addition, this peptide was found to decrease leptin while increasing adiponectin.

To their relief, scientists have found no harmful side effects from this peptide. Using different dosages of the Ace 031 peptide resulted in both minor and temporary side effects.

Some test subjects reported headaches, nosebleeds, and injection site reactions after receiving the ACE-031. As far as safety and efficacy are concerned, more research is required before being legally used on humans.


Formula: C33H57N11O9

Molar mass: 1311.45

Unit Quantity: 1 Vial

Appearance: White Powder

Peptide Purity: >99%

Reviews

There are no reviews yet.

Be the first to review “ACE-031”

Your email address will not be published. Required fields are marked *